The FDA approved nivolumab for some patients with melanoma whose tumor was completely removed through surgery and has not spread. The U.S. Food and Drug Administration (FDA) has approved the checkpoint inhibitor nivolumab (Opdivo)...
The FDA approved encorafenib with binimetinib as a treatment for certain patients with non-small cell lung cancer. The U.S. Food and Drug Administration has approved encorafenib (Braftovi) with binimetinib (Mektovi) to treat adult patients...
A targeted therapy previously approved for adults is now available for certain pediatric patients with blood cancer. The U.S. Food and Drug Administration (FDA) has approved bosutinib (Bosulif) for pediatric patients who are at...
The FDA Project Renewal initiative has updated the approved indications for temozolomide chemotherapy in anaplastic astrocytoma. The U.S. Food and Drug Administration (FDA) has approved updated labeling of temozolomide (Temodar), including new and revised...
The FDA approved a kit that allows for liver-directed delivery of the chemotherapy melphalan to treat metastatic liver disease from uveal melanoma. The U.S. Food and Drug Administration (FDA) has approved a kit for...
The FDA has approved another T-cell engager therapy for patients with heavily pretreated multiple myeloma The U.S. Food and Drug Administration (FDA) has granted accelerated approval to elranatamab-bcmm (Elrexfio) for the treatment of adult...
The FDA approved a combination of the PARP inhibitor niraparib with a hormone therapy agent for certain patients with metastatic prostate cancer The U.S. Food and Drug Administration (FDA) has approved the combination of...
The FDA granted full approval to pralsetinib as a treatment for certain patients with non-small cell lung cancer The U.S. Food and Drug Administration has granted full approval to pralsetinib (Gavreto) to treat adult...
Certain patients with advanced multiple myeloma may be eligible for treatment with a new immunotherapy drug. The U.S. Food and Drug Administration (FDA) has granted accelerated approval to talquetamab-tgvs (Talvey) for patients with multiple...
The FDA approved a combination of trifluridine, tipiracil, and bevacizumab for the treatment of heavily pretreated metastatic colorectal cancer. The U.S. Food and Drug Administration (FDA) has approved trifluridine and tipiracil (Lonsurf), in combination...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More